CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC. Pacheco JM, Schenk EL. J Thorac Oncol 2021;16:509-511.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Pacheco JM, Schenk EL. CD73 and Adenosine Receptor Signaling as a Potential Therapeutic Target in EGFR-Mutated NSCLC. J Thorac Oncol 2021;16:509-511.
PMID: 33781438